New dopaminergic agonists

被引：0
|
作者：
De Mattos, JP [1 ]
Mattos, VMDC [1 ]
机构：
[1] Univ Fed Rio de Janeiro, Serv Neurol, Hosp Univ Clementino Fraga Filho, BR-21941 Rio De Janeiro, Brazil
来源：
ARQUIVOS DE NEURO-PSIQUIATRIA | 1999年 / 57卷 / 2A期
关键词：
levodopa; dopaminergic agonists; Parkinson's disease;
D O I：
10.1590/S0004-282X1999000200029
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
We present a brief review of the literature about dopaminergic a,agonists. We report the five known dopaminergic receptors, where they are located, the advantages and disadvantages of the employment in parkinsonian patients. The dopaminergic agonists were introduced to control the limitations of levodopa-increasing the therapheutic window. We analyse the pharmacocynetic efficacy and the side effects of cabergoline, ropinirole and pramipexole.
引用
收藏
页码：329 / 332
页数：4
相关论文
共 50 条
  • [41] Is there room for new non-dopaminergic treatments in Parkinson’s disease?
    Manuela Pilleri
    Konstantinos Koutsikos
    Angelo Antonini
    Journal of Neural Transmission, 2013, 120 : 349 - 352
  • [42] The relevance of dopaminergic level in nocturnal disability in Parkinson's disease: implications of continuous dopaminergic stimulation at night to treat the symptoms
    Stocchi, Fabrizio
    Stirpe, Paola
    JOURNAL OF NEURAL TRANSMISSION, 2014, 121 : S79 - S83
  • [43] Dopaminergic and non-dopaminergic gait components assessed by instrumented timed up and go test in Parkinson's disease
    Dibilio, Valeria
    Nicoletti, Alessandra
    Mostile, Giovanni
    Toscano, Simona
    Luca, Antonina
    Raciti, Loredana
    Sciacca, Giorgia
    Vasta, Rosario
    Cicero, Calogero Edoardo
    Contrafatto, Donatella
    Zappia, Mario
    JOURNAL OF NEURAL TRANSMISSION, 2017, 124 (12) : 1539 - 1546
  • [44] The relevance of dopaminergic level in nocturnal disability in Parkinson’s disease: implications of continuous dopaminergic stimulation at night to treat the symptoms
    Fabrizio Stocchi
    Paola Stirpe
    Journal of Neural Transmission, 2014, 121 : 79 - 83
  • [45] Effects of dopaminergic and subthalamic stimulation on musical performance
    van Vugt, Floris T.
    Schuepbach, Michael
    Altenmueller, Eckart
    Bardinet, Eric
    Yelnik, Jerome
    Haelbig, Thomas D.
    JOURNAL OF NEURAL TRANSMISSION, 2013, 120 (05) : 755 - 759
  • [46] Dopamine agonists in Parkinson's disease
    Tintner, R
    Jankovic, J
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (11) : 1803 - 1820
  • [47] Response of parkinsonian swallowing dysfunction to dopaminergic stimulation
    Hunter, PC
    Crameri, J
    Austin, S
    Woodward, MC
    Hughes, AJ
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1997, 63 (05) : 579 - 583
  • [48] Hypnic Headache with Dopaminergic Neuron Dysfunction: New Insight from a Rare Case
    Zhang, Yi
    Wang, Chengze
    Chen, Yuan
    Wang, Ruifang
    Lian, Yajun
    PAIN MEDICINE, 2019, 20 (08) : 1639 - 1642
  • [49] The Renin-Angiotensin System Modulates Dopaminergic Neurotransmission: A New Player on the Scene
    Kobiec, Tamara
    Otero-Losada, Matilde
    Chevalier, Guenson
    Udovin, Lucas
    Bordet, Sofia
    Menendez-Maissonave, Camila
    Capani, Francisco
    Perez-Lloret, Santiago
    FRONTIERS IN SYNAPTIC NEUROSCIENCE, 2021, 13
  • [50] Selective dopaminergic vulnerability in Parkinson's disease: new insights into the role of DAT
    Harraz, Maged M.
    FRONTIERS IN NEUROSCIENCE, 2023, 17
12345